QA: ANAPTYSBIO INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001370053_2023_ANAPTYSBIO_INC.pdf

Logs

Graph

Absolute values for 0001370053, ANAPTYSBIO INC

  xvar xval
0 AssetsCurrent 447,205,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,089,000
3 remainder_Assets 161,089,000
4 LiabilitiesCurrent 26,054,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 36,643,000
9 ResearchAndDevelopmentExpense 88,798,000
10 remainder_Expenses 24,000
11 remainder_Revenues 10,287,000
12 remainder_NetIncome -13,546,000
13 remainder_ComprehensiveNetIncome -4,824,000
  yvar yval
0 Assets 610,383,000
1 Liabilities 26,054,000
2 Expenses 125,465,000
3 Revenues 10,287,000
4 StockholdersEquity 584,329,000
5 NetIncome -128,724,000
6 ComprehensiveNetIncome -131,136,000
7 BaseVar 395,279,500
8 EconomicCapitalRatio 2.75

Edgar->Model Mapping

Feature Distribution

Change over Time